C-Sections Tied to “Stunted” Microbiota in Newborns: Study

Research on hundreds of babies finds the delivery method is linked with a greater abundance of taxa more frequently seen in hospitals.

Written byShawna Williams
| 2 min read
a baby just born by c-section

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, MURATSEYIT

Newborns delivered by C-section tend to have more gut microbes associated with hospitals than their vaginally delivered peers, according to a study published today (September 18) in Nature—but the health effects, if any, of that difference are unclear.

Previous studies have linked C-sections with an increased risk of conditions such as asthma and diabetes, leading some researchers to suspect that babies born in this way may have different mixes of gut bacteria because of their lack of exposure to the birth canal. But studies of whether babies born by C-section do have microbiomes that are distinct from vaginally delivered infants have yielded conflicting results.

“Caesarean sections are a life-saving and medically necessary intervention,” says Lisa Stinson, a molecular microbiologist and reproductive biologist of the University of Western Australia who was not involved in the new study, in an interview with Science News. But, she adds, “we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies